Developmental neuroscience

Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021

Retrieved on: 
Wednesday, August 4, 2021
Branches of biology, Neurological disorders, Neuroscience, Developmental neuroscience, Neurodevelopmental disorder, Rett syndrome, Parkinson

Webcast for the conference will be available in the Investors section under "Events" of the Anavex corporate website at www.anavex.com .

Key Points: 
  • Webcast for the conference will be available in the Investors section under "Events" of the Anavex corporate website at www.anavex.com .
  • To listen to the live event, please contact a BTIG representative with interest.
  • About Anavex Life Sciences Corp.
    Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimers disease, Parkinsons disease, Rett syndrome and other central nervous system (CNS) diseases, pain, and various types of cancer.
  • All forward-looking statements are qualified in their entirety by this cautionary statement and Anavex Life Sciences Corp. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

A New Resource for Families in the Greater Wausau Area: A Therapy Center Designed for Children on the Autism Spectrum

Retrieved on: 
Thursday, July 29, 2021
Branches of biology, Psychiatric diagnosis, Psychiatry, Abnormal psychology, Autism, Learning disabilities, Autism spectrum, Developmental neuroscience, Developmental psychology, Autism Speaks, Autism rights movement

The center is a colorful, child-friendly place created especially for young people with autism.

Key Points: 
  • The center is a colorful, child-friendly place created especially for young people with autism.
  • Caravel previously offered in-home therapy in the Greater Wausau area.
  • Since 2009, Caravel Autism Health has been devoted to helping families navigate the challenges of childhood autism.
  • Our team of clinical experts specializes in the evaluation, diagnosis, and treatment of children on the autism spectrum.

Lighthouse Autism Center and Cerberus Announce Strategic Partnership

Retrieved on: 
Monday, July 26, 2021
General Health, Finance, Other Health, Health, Professional services, Branches of biology, Psychiatric diagnosis, Psychiatry, Neuroscience, Autism, Autism spectrum, Developmental neuroscience, Developmental psychology, Cerberus Capital Management, Draft:Hopebridge Autism Therapy Centers, Outline of autism, Lighthouse Autism Center, Cerberus, Abry Partners, LIGHTHOUSE AUTISM CENTER, CERBERUS, ABRY PARTNERS

Lighthouse Autism Center (Lighthouse or the Company) today announced a strategic investment by an affiliate of Cerberus Capital Management (Cerberus), a global leader in alternative investing.

Key Points: 
  • Lighthouse Autism Center (Lighthouse or the Company) today announced a strategic investment by an affiliate of Cerberus Capital Management (Cerberus), a global leader in alternative investing.
  • Lighthouse is a leading provider of center-based applied behavioral analysis (ABA) services for children diagnosed with autism spectrum disorder.
  • Nicholas Scola, Partner at Abry Partners, added: "We are excited to continue our partnership with the Lighthouse team and welcome the support of Cerberus.
  • Headquartered in South Bend, Indiana, Lighthouse is a leading provider of center-based autism behavioral health services for children diagnosed with autism spectrum disorder.

Receptor Life Sciences Announces Initiation of IND-Opening Clinical PK Study of RLS102 for Irritability in Autism Spectrum Disorder

Retrieved on: 
Monday, July 19, 2021
Health, FDA, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Branches of biology, Psychiatric diagnosis, Psychiatry, Neuroscience, Autism, Developmental neuroscience, Developmental psychology, Learning disabilities, Autism spectrum, Irritability, Developmental disorder, Autism therapies

This first-in-class, pure synthetic CBD capsule is being investigated for the treatment of irritability in patients with autism spectrum disorder.

Key Points: 
  • This first-in-class, pure synthetic CBD capsule is being investigated for the treatment of irritability in patients with autism spectrum disorder.
  • Following the IND acceptance, RLS initiated a pharmacokinetic (PK), formulation selection study using RLS102 in healthy volunteers.
  • RLS102 has the potential to be a new treatment to reduce irritability in patients living with autism spectrum disorder, said Mark Theeuwes, President and CEO, Receptor Life Sciences.
  • A complex developmental disorder often associated with a high level of irritability, autism spectrum disorder (ASD) affects about 5 million adults in the United States ( https://www.cdc.gov/ncbddd/autism/features/adults-living-with-autism-spe... ).

Autism Care Partners Acquires Autism Bridges, Expands Services to Children With Autism Throughout the Northeast

Retrieved on: 
Tuesday, July 13, 2021
Branches of biology, Psychiatric diagnosis, Psychiatry, Abnormal psychology, Autism, Autism spectrum, Developmental neuroscience, Developmental psychology, Draft:Hopebridge Autism Therapy Centers

I'm eager to start working with the Bridges team to accelerate the delivery of evidence-based autism services throughout the Northeast.

Key Points: 
  • I'm eager to start working with the Bridges team to accelerate the delivery of evidence-based autism services throughout the Northeast.
  • Founded in 1992 as an Early Intervention provider in New York City, Autism Care Partners has become a recognized leader in the delivery of comprehensive behavioral therapy to individuals on the autism spectrum.
  • The combined platform will continue to be led by Jim Spink, CEO with Thea Davis BCBA joining as the CCO.
  • Founded in 2007, Autism Bridges specializes in the delivery of high-quality individualized ABA programming for young children diagnosed with autism and serves communities in New Hampshire, Vermont, and Massachusetts.

The Most Famous Artist Mints First NFT from Human Fecal Matter to Fund Gut-Brain Research Grant

Retrieved on: 
Tuesday, June 29, 2021
Branches of biology, Medical specialties, Autism, Autism spectrum, Developmental neuroscience, Developmental psychology, Psychiatric diagnosis, Human feces, Non-fungible token

Commissioned by microbial sciences company, Seed Health , all proceeds of the NFT will fund a gut-brain research grant for autism spectrum disorder (ASD).

Key Points: 
  • Commissioned by microbial sciences company, Seed Health , all proceeds of the NFT will fund a gut-brain research grant for autism spectrum disorder (ASD).
  • It is a diagnostic tool containing microbial, chemical, physiological and functional indicators of human health," stated Dr. Christopher Mason.
  • 7792, 2020, doi:10.1038/d41586-020-00198-y
    The first NFT (Non-Fungible Token) made from human fecal matter (CHN, containing ~10 Bacteria; Various Strains).
  • Matty Mo is a New Mexico-based artist and entrepreneur best known for creating the social token-powered global community known as "The Most Famous Artist."

The Most Famous Artist Mints First NFT from Human Fecal Matter to Fund Gut-Brain Research Grant

Retrieved on: 
Tuesday, June 29, 2021
Branches of biology, Medical specialties, Autism, Autism spectrum, Developmental neuroscience, Developmental psychology, Psychiatric diagnosis, Human feces, Non-fungible token

Commissioned by microbial sciences company, Seed Health , all proceeds of the NFT will fund a gut-brain research grant for autism spectrum disorder (ASD).

Key Points: 
  • Commissioned by microbial sciences company, Seed Health , all proceeds of the NFT will fund a gut-brain research grant for autism spectrum disorder (ASD).
  • It is a diagnostic tool containing microbial, chemical, physiological and functional indicators of human health," stated Dr. Christopher Mason.
  • 7792, 2020, doi:10.1038/d41586-020-00198-y
    The first NFT (Non-Fungible Token) made from human fecal matter (CHN, containing ~10 Bacteria; Various Strains).
  • Matty Mo is a New Mexico-based artist and entrepreneur best known for creating the social token-powered global community known as "The Most Famous Artist."

Rett Syndrome Research Trust Announces Development of the ORCA Measure to Assess Communication Ability of Individuals with Rett Syndrome

Retrieved on: 
Thursday, June 17, 2021
Branches of biology, Neurological disorders, Clinical medicine, Health, Learning disabilities, Psychiatric diagnosis, Developmental neuroscience, Pervasive developmental disorders, Rett, Neurodevelopmental disorder, Angelman syndrome

"Most individuals with Rett Syndrome have great difficulties communicating, so parents and caregivers are often at a loss in understanding their loved one's needs and wants," said Monica Coenraads, Chief Executive Officer of the Rett Syndrome Research Trust (RSRT).

Key Points: 
  • "Most individuals with Rett Syndrome have great difficulties communicating, so parents and caregivers are often at a loss in understanding their loved one's needs and wants," said Monica Coenraads, Chief Executive Officer of the Rett Syndrome Research Trust (RSRT).
  • Currently, there is no comprehensive tool to assess communication among individuals with Rett Syndrome.
  • The tool was created to measure communication abilities in individuals living with Angelman Syndrome, another neurodevelopmental disorder with communication challenges similar to Rett Syndrome.
  • Scientists estimate that the Rett ORCA study will need to enroll 270 Rett Syndrome families in order to satisfy the requirements for FDA validation.

MOVIA Robotics Welcomes Josias Reynoso to Its Team, Offering His Knowledge and Perspective as a Youth on the Autism Spectrum

Retrieved on: 
Monday, June 14, 2021
Branches of biology, Psychiatric diagnosis, Psychiatry, Neuroscience, Autism, Autism spectrum, Developmental neuroscience, Developmental psychology

is proud to welcome Josias Reynoso as the newest member of its growing team.

Key Points: 
  • is proud to welcome Josias Reynoso as the newest member of its growing team.
  • He brings with him to MOVIA his knowledge of robotics, coding and passion for teaching, as well as his own personal growth experience as a youth on the Autism Spectrum.
  • Josias will also be working on a MOVIA STEAM initiative to help expose children at a young age to coding and other STEAM related activities.
  • In addition, Josias will be engaging with customers to provide perspective and "hope" while on Zoom training calls and in person.

Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the Associated Professional Sleep Societies SLEEP 2021 Annual

Retrieved on: 
Friday, June 11, 2021
Branches of biology, Psychiatry, Psychiatric diagnosis, Abnormal psychology, Autism, Pervasive developmental disorders, Developmental neuroscience, Developmental psychology, Autism spectrum, Conditions comorbid to autism spectrum disorders, Autism therapies

Furthermore, the children with both DEE and autism spectrum disorder (ASD) showed more wide-ranging benefits on sleep compared to those with DEE alone.

Key Points: 
  • Furthermore, the children with both DEE and autism spectrum disorder (ASD) showed more wide-ranging benefits on sleep compared to those with DEE alone.
  • Epilepsy and sleep disorders have a bidirectional relationship and co-occur in individuals with ASD.
  • While these results are exploratory in nature, they are encouraging and warrant confirmation in future clinical trials of Zygel in patients with DEE and/or ASD.
  • Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release.